Polymarket
Which companies will be acquired before 2027?
iRobot
ZM · NASDAQ
buy · 20 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| July 2, 2026 | Needham | Maintains | Buy | $130.00 |
| June 30, 2026 | RBC Capital | Reiterates | Outperform | $130.00 |
| June 2, 2026 | HSBC | Maintains | Buy | $133.00 |
| May 26, 2026 | Citigroup | Maintains | Buy | $126.00 |
| May 22, 2026 | Jefferies | Maintains | Buy | $118.00 |
| May 22, 2026 | Morgan Stanley | Maintains | Equal-Weight | $105.00 |
| May 22, 2026 | Wells Fargo | Maintains | Equal-Weight | $105.00 |
| May 22, 2026 | RBC Capital | Maintains | Outperform | $130.00 |
| May 22, 2026 | Cantor Fitzgerald | Maintains | Neutral | $104.00 |
| May 22, 2026 | Benchmark | Maintains | Buy | $125.00 |
| May 22, 2026 | Rosenblatt | Maintains | Buy | $130.00 |
| May 22, 2026 | Piper Sandler | Maintains | Neutral | $107.00 |
| May 22, 2026 | Mizuho | Maintains | Outperform | $120.00 |
| May 22, 2026 | BTIG | Maintains | Buy | $125.00 |
| May 22, 2026 | Needham | Maintains | Buy | $130.00 |
| May 21, 2026 | Benchmark | Maintains | Buy | $121.00 |
| May 19, 2026 | Baird | Maintains | Outperform | $105.00 |
| May 15, 2026 | Citigroup | Maintains | Buy | $122.00 |
| March 13, 2026 | Needham | Reiterates | Buy | $100.00 |
| February 26, 2026 | Bernstein | Maintains | Market Perform | $88.00 |
| February 26, 2026 | Keybanc | Maintains | Underweight | $74.00 |
| February 26, 2026 | BTIG | Maintains | Buy | $100.00 |
| February 26, 2026 | Rosenblatt | Maintains | Buy | $115.00 |
| February 24, 2026 | Benchmark | Maintains | Buy | $110.00 |
| January 12, 2026 | Citigroup | Upgrades | Buy | $106.00 |
| January 5, 2026 | Piper Sandler | Maintains | Neutral | $91.00 |
| November 25, 2025 | Jefferies | Maintains | Buy | $105.00 |
| November 25, 2025 | Morgan Stanley | Maintains | Equal-Weight | $92.00 |
| November 25, 2025 | RBC Capital | Reiterates | Outperform | $100.00 |
| November 25, 2025 | JP Morgan | Maintains | Neutral | $90.00 |
| November 25, 2025 | Cantor Fitzgerald | Reiterates | Neutral | $87.00 |
| November 25, 2025 | Wedbush | Reiterates | Outperform | $95.00 |
| November 25, 2025 | Rosenblatt | Maintains | Buy | $115.00 |
| November 25, 2025 | Needham | Reiterates | Buy | $100.00 |
| November 17, 2025 | Citigroup | Maintains | Neutral | $94.00 |
| November 11, 2025 | Rosenblatt | Maintains | Buy | $115.00 |
| October 20, 2025 | UBS | Assumes | Neutral | $85.00 |
| September 18, 2025 | Stifel | Maintains | Hold | $90.00 |
| September 18, 2025 | RBC Capital | Reiterates | Outperform | $100.00 |
| September 18, 2025 | Cantor Fitzgerald | Reiterates | Neutral | $87.00 |
| September 18, 2025 | Benchmark | Maintains | Buy | $110.00 |
| September 18, 2025 | Rosenblatt | Maintains | Buy | $110.00 |
| September 18, 2025 | Needham | Reiterates | Buy | $100.00 |
| August 26, 2025 | Mizuho | Maintains | Outperform | $100.00 |
| August 25, 2025 | Citigroup | Maintains | Neutral | $85.00 |
Live event probabilities associated with this company or market.
Polymarket
iRobot
Zoom's AI Companion paid users grew 184% year-over-year, with Contact Center expanding at high double-digit rates. CFRA analysts expect AI monetization products to drive continued growth momentum, and the company raised its full-year forecasts following a strong Q1 earnings beat.
Despite AI-driven optimism, Wall Street maintains a cautious 'Hold' consensus, with 19 analysts rating the stock neutrally. Revenue growth is forecast at only 3.3% per annum over three years, and earnings are expected to decline 9.4% per annum, raising questions about AI's ability to meaningfully move the needle.
Zoom raised its full-year adjusted EPS guidance to $5.96–$6.00 and revenue to $5.08–$5.09 billion after beating Q1 estimates. Consensus earnings estimates for the current and next fiscal years show modest but positive year-over-year growth of +2.4% and +2.7%, respectively.
Zoom's Q2 guidance came in below analyst expectations on both revenue and EPS. Current quarter EPS is expected to decline 2.6% year-over-year, and the stock has underperformed significantly, falling 13.6% over the past month versus the S&P 500's -1.3% during the same period.
Zoom shares trade above their 8-day, 20-day, and 200-day simple and exponential moving averages, generating multiple buy signals. The stock is up 12% year-to-date and has shown a meaningful recovery, with shares rising over 4% in the past month, reflecting renewed investor confidence.
Technical analysis assigns ZM a score of 33 — 34% below its historic median — flagging higher-than-normal risk. The MACD indicator is negative at -0.71, and the stock is rated a 'Sell' overall. The RSI also suggests the stock is overbought relative to recent momentum, limiting further upside.